How Your Body Processes a New Tablet Medicine With and Without Food
Treatments studied
This early-stage study tests how a new medicine called sonrotoclax is absorbed and processed by your body when taken as a tablet with and without food. Researchers want to understand the best way to take this medicine to help it work effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in overall good health with no serious medical conditions
- Your body mass index (BMI) must be between 18 and 32
- Your B-cell count (a type of immune cell) must be above 150 cells per microliter
- You cannot have had stomach or bowel surgery that affects how your body absorbs medicine (appendix removal and hernia repair are okay)
- You must not take other medications that interfere with how your body processes drugs for at least 30 days before the study
- You cannot have had a serious infection in the 4 weeks before starting the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how two different tablet versions of the study drug BGB-58067 enter the body and how food affects the drug. Healthy volunteers take the drug to help understand the best way to give it in future trials.
This study tests a new tablet called VV261 in healthy volunteers. It looks at how the drug moves through the body and how safe it is when taken multiple times. It may help show if the drug is promising for future treatments.
This trial studies how food changes the way your body processes a new medicine called VV119. It helps make sure the drug works safely and effectively. Healthy adults are needed to participate.
This trial tests how a study drug called florensocatib is absorbed into your blood. It compares taking the drug alone versus with a common stomach acid reducer. This helps researchers understand how to best give the medicine.
This early-stage study tests how a new tablet medicine (HRS-2189) moves through your body and how well it's absorbed. Healthy volunteers take the tablet, and researchers measure drug levels in your blood over time to understand if the tablet works as designed.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.